Article
Higher Circulating Testosterone Linked to Higher CAD Risk in Men: Mendelian Randomization and Survival Analyses.
The Journal of clinical endocrinology and metabolism - 17 Mar 2026
Morbey Emily J, Day Felix R, Butterworth Adam S, Wareham Nicholas J, Perry John R B, Ong Ken K
Abstract excerpt
CONTEXT: Testosterone supplementation is increasingly widespread and has well-established beneficial effects on sexual function and metabolic health. However, there remains uncertainty regarding associated cardiovascular risks. OBJECTIVE: Human genetics studies demonstrated that Mendelian randomization approaches recapitulate the beneficial effects of testosterone therapy; here we apply this to cardiovascular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
